PREDICTION OF EARLY DEVELOPMENT OF CHRONIC NONRHEUMATIC ATRIAL-FIBRILLATION

被引:0
|
作者
SAKAMOTO, H [1 ]
OKAMOTO, EI [1 ]
IMATAKA, K [1 ]
IEKI, K [1 ]
FUJII, J [1 ]
机构
[1] ASAHI LIFE FDN,INST ADULT DIS,TOKYO,JAPAN
来源
JAPANESE HEART JOURNAL | 1995年 / 36卷 / 02期
关键词
AGE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; CARDIOTHORACIC RATIO; F-WAVE AMPLITUDE; LEFT ATRIAL DIMENSION; LEFT VENTRICULAR EJECTION FRACTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to identify predictors of development of chronic nonrheumatic atrial fibrillation within one year of onset, thereby minimizing the risk of embolic complications and death. We retrospectively studied 137 patients with new-onset nonrheumatic atrial fibrillation. Chronic atrial fibrillation developed in 30 patients at the end of one year (chronic group). Atrial fibrillation remained paroxysmal in 107 patients (paroxysmal group). Clinical characteristics, electrocardiograms, and echocardiograms at the time of the onset of atrial fibrillation were compared in the two groups. Patients in the chronic group were significantly older than patients in the paroxysmal group (70.1 +/- 8.2 vs. 62.4 +/- 11.0 years, p < 0.01) and had a significantly higher incidence of congestive heart failure (13% vs. 3%, p < 0.05) and diabetes mellitus (37% vs. 19%, p < 0.05). The chronic group also exhibited higher cardiothoracic ratio (52.0 +/- 5.7% vs. 47.6 +/- 5.0%, p < 0.01), greater f-wave amplitude in lead V-1 (1.48 +/- 0.91 vs. 1.06 +/- 0.45 mm, p < 0.05), larger left atrial dimension (41.0 +/- 6.4 vs. 34.2 +/- 7.6 mm, p < 0.01), and lower left ventricular ejection fraction (71.4 +/- 5.6% vs. 75.5 +/- 8.2%, p < 0.05). The presence of four or more of the following seven factors strongly predicted the development of chronic nonrheumatic atrial fibrillation within one year (88% to 100%): age greater than or equal to 65 years, congestive heart failure, diabetes mellitus, cardiothoracic ratio greater than or equal to 50%, f-wave amplitude greater than or equal to 2.0 mm, left atrial dimension greater than or equal to 38 mm, and ejection fraction less than or equal to 76%.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 50 条
  • [41] COARSENESS OF NONRHEUMATIC ATRIAL-FIBRILLATION - AN ANALYSIS OF 464 PATIENTS FOLLOWED FOR 1.3 YEARS
    BLACKSHEAR, JL
    SAFFORD, RE
    PEARCE, LA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A253 - A253
  • [42] USE OF WARFARIN IN NONRHEUMATIC ATRIAL-FIBRILLATION - A COMMENTARY FROM GENERAL-PRACTICE
    SWEENEY, KG
    GRAY, DP
    STEELE, R
    EVANS, P
    BRITISH JOURNAL OF GENERAL PRACTICE, 1995, 45 (392): : 153 - 158
  • [43] LEFT ATRIAL SPONTANEOUS CONTRAST IN DC-CARDIOVERSION FOR NONRHEUMATIC ATRIAL-FIBRILLATION WITHOUT ANTICOAGULATION
    VERHORST, PMJ
    KAMP, O
    VERHEUGT, FWA
    VISSER, CA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A128 - A128
  • [44] THE EFFECT OF ASPIRIN ON THE RISK OF STROKE IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION - THE BAATAF STUDY
    SINGER, DE
    HUGHES, RA
    GRESS, DR
    SHEEHAN, MA
    OERTEL, LB
    MARAVENTANO, SW
    BLEWETT, DR
    ROSNER, B
    KISTLER, JP
    AMERICAN HEART JOURNAL, 1992, 124 (06) : 1567 - 1573
  • [45] COMPARISON OF CT IN PATIENTS WITH CEREBRAL-ISCHEMIA WITH OR WITHOUT NONRHEUMATIC ATRIAL-FIBRILLATION
    VANLATUM, JC
    KOUDSTAAL, PJ
    KAPPELLE, LJ
    VANKOOTEN, F
    ALGRA, A
    VANGIJN, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (02): : 132 - 137
  • [46] ORAL ANTICOAGULATION FOR PREVENTION OF THROMBOEMBOLISM IN NONRHEUMATIC ATRIAL-FIBRILLATION - INDICATIONS, EFFICACY, AND RISK
    KOTTKAMP, H
    WILLEMS, S
    HINDRICKS, G
    CHEN, X
    HAVERKAMP, W
    HASFELD, M
    BORGGREFE, M
    BREITHARDT, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 (11): : 667 - 673
  • [47] LEFT-VENTRICULAR MASS AS A DETERMINANT OF CARDIOVASCULAR DEATH IN NONRHEUMATIC ATRIAL-FIBRILLATION
    DOMINGUEZ, A
    FRIEDMAN, HS
    NGUYEN, T
    MANDEL, G
    VASAVADA, B
    CLINICAL RESEARCH, 1990, 38 (02): : A490 - A490
  • [48] USEFULNESS OF LABETALOL IN CHRONIC ATRIAL-FIBRILLATION
    WONG, CK
    LAU, CP
    LEUNG, WH
    CHENG, CH
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (17): : 1212 - 1215
  • [49] CHRONIC NICOTINE INGESTION AND ATRIAL-FIBRILLATION
    STEWART, PM
    CATTERALL, JR
    BRITISH HEART JOURNAL, 1985, 54 (02): : 222 - 223
  • [50] MANAGEMENT OF PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION
    SALHADIN, P
    BRAN, M
    DEMARNEFFE, M
    DENOLIN, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 : S295 - S296